Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Axcelead Drug Discovery Partners Inc HQ Fujisawa Kanagawa Japan Axcelead DDP and Superluminal Medicines Inc HQ Boston Massachusetts USA Superluminal announced the intention to collaborate on drug discovery targeting specific molecular mechanisms asso...
Telix today announces that the United States US Food and Drug Administration FDA has approved a label expansion for Illuccix kit for the preparation of gallium Ga gozetotide for injection to include patient selection for radioligand therapy RLT in th...
Revolution Medicines Inca latestage clinical oncology company developing targeted therapies for patients with RASaddicted cancers today announced that the US Food and Drug Administration FDA has granted Breakthrough
Formation Bio an AInative pharma company focused on accelerating drug development today announced that its subsidiary Libertas Bio has licensed gusacitinib an oral dual JAKSYK inhibitor to Sanofi Sanofi will explore its potential in a new indication...
Illumina Inc announced today it has entered into a definitive agreement with Standard BioTools NASDAQ LAB under which Illumina will acquire SomaLogic a leader in datadriven proteomics technology and other specified assets for million in cash payable...
Exelixis Inctoday announced positive topline results from the STELLAR phase pivotal trial in which zanzalintinib in combination with atezolizumab Tecentriq demonstrated a statistically significant
Simcere Pharmaceutical HK announced that QUVIVIQ generic name Daridorexant Hydrochloride Tablets an antiinsomnia drug developed in collaboration with Idorsia in Switzerland
XtalPi a global leader in AI and roboticspowered drug and materials discovery today announced it has signed a Letter of Intent LOI with DoveTree LLC founded by Harvard University Professor and renowned biopharma
Ipsen announced today that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has issued a positive opinion for Cabometyx cabozantinib for adult patients with unresectable or metastatic
Everest Medicinesa biopharmaceutical company focused on the discovery clinical development manufacturing and commercialization of innovative therapeutics today announced the successful release of the first clinical batch of EVM
